Year: 2020
Type: article
Abstract: Neurotrophic receptor tyrosine kinase (NTRK) fusions are rare, therapeutically actionable, and, in some cases, diagnostic oncogenic events that can occur in a variety of adult and pediatric cancers. Cytopathologists need to be a familiar with the types of tumors that can harbor NTRK fusions to triage specimens accordingly for testing.
Source: Cancer Cytopathology
DOI: 10.1002/cncy.22350
Authors: Roberto Ruiz‐Cordero, Dianna L. Ng
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W3089953150
